Asterias Biotherapeutics (AST) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free AST Stock Alerts $0.0020 0.00 (0.00%) (As of 07/10/2019) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 8:00 AM | businesswire.comApplications Software Technology Acquires Symatrix to Accelerate Global Expansion in Oracle Cloud ServicesApril 30, 2024 | uk.finance.yahoo.comBritish & American Investment Trust Plc - Annual Financial ReportMarch 27, 2024 | seekingalpha.comCLDI Calidi Biotherapeutics, Inc.February 17, 2024 | morningstar.comProtalix BioTherapeutics Inc PLXNovember 27, 2023 | benzinga.comCalidi Biotherapeutics Stock (AMEX:CLDI) Dividends: History, Yield and DatesNovember 22, 2023 | morningstar.comBarinthus Biotherapeutics PLC ADRNovember 2, 2023 | morningstar.comCalidi Biotherapeutics Inc Ordinary Shares - Class AJuly 18, 2023 | benzinga.comArcutis Biotherapeutics Stock (NASDAQ:ARQT), Analyst Ratings, Price Targets, PredictionsMay 21, 2023 | fool.comIovance Biotherapeutics (NASDAQ: IOVA)May 11, 2023 | marketwatch.comHuman Embryonic Stem Cells (HESC) Market Future Investments and Forecast Till 2030May 8, 2023 | investing.comBrightPath Biotherapeutics Co Ltd (4594)March 14, 2023 | marketwatch.comHuman Embryonic Stem Cells (HESC) Market: Analyzing Growth Opportunities and Industry Trends for 2023-2028March 9, 2023 | marketwatch.com2023-2029 Human Embryonic Stem Cells (HESC) Market Size and Regional Analysis | Research Report by Absolute ReportsMarch 7, 2023 | marketwatch.comStem Cell Therapy for Osteoarthritis Market Expert Industrial Investigation Report 2023-2028March 6, 2023 | marketwatch.comTherapeutic Cancer Vaccines Market 2023 | Global Industry Report Forecast 2029February 27, 2023 | marketwatch.comEmerging Opportunities in Therapeutic Cancer Vaccines Market from 2023 to 2027February 20, 2023 | seekingalpha.comAtara Biotherapeutics, Inc. 2023 Q4 - Results - Earnings Call PresentationFebruary 14, 2023 | marketwatch.comTherapeutic Cancer Vaccines Market Outlook 2023 and Forecast to 2028 with Top Countries DataJanuary 30, 2023 | finance.yahoo.comBridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023January 20, 2023 | seekingalpha.comSONN Sonnet BioTherapeutics Holdings, Inc.January 19, 2023 | marketwatch.comHuman Embryonic Stem Cells (HESC) Market By Industry Research, Supply, Size, Share and Prospects 2023-2028January 11, 2023 | marketwatch.comSonnet BioTherapeutics Shares Up 8% on Roche CollaborationJanuary 5, 2023 | finance.yahoo.comKling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive OfficerDecember 20, 2022 | finance.yahoo.comSensei Biotherapeutics Slashes Workforce, Closes R&D SiteNovember 27, 2022 | marketwatch.comHuman Embryonic Stem Cells (HESC) Market 2022 Statistics, Industry Share, Latest Trends, Growth Drivers, Size Estimate and Forecast till 2028November 27, 2022 | marketwatch.comHuman Embryonic Stem Cells (HESC) Market 2022 Statistics, Industry Share, Latest Trends, Growth Drivers, Size Estimate and Forecast till 2028November 25, 2022 | marketwatch.comTherapeutic Cancer Vaccines Market 2023 : SWOT Analysis by Players Continues Explosive Growth by 2028October 16, 2022 | markets.businessinsider.comAtara, Pierre Fabre Announce CHMP Adopts Positive Opinion Recommending Approval Of EbvalloOctober 14, 2022 | finance.yahoo.comTILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian CancerMarch 28, 2022 | investing.comNavana CNG Ltd (NAVA)February 25, 2022 | investing.comAsterias Biotherapeutics Inc (AST)January 15, 2022 | marketwatch.comGlobal Spinal Cord Trauma Treatment Market Price, Vendors, Share, Future Opportunities, Potential Business Strategies Analysis 2022 to 2027October 14, 2021 | benzinga.commRNA Synthesis and Manufacturing Services Markets...August 9, 2021 | marketwatch.comTelomerase Reverse Transcriptase Market Report 2021 Growth Factors, Product Type, Manufacturers, Application, End User and Regions 2027 Get Asterias Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AST and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. AST Media Mentions By Week AST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AST News Sentiment▼0.000.43▲Average Medical News Sentiment AST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AST Articles This Week▼10▲AST Articles Average Week Get Asterias Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NBY News NVTA News BOMH News PPCB News ABMT News HDVY News STAB News BRSH News PKBO News PRED News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:AST) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyNew Options need New Trading StrategiesNetpicksThis military-backed stock “owns” AI marketPorter & CompanyYou won’t see these trades on TVProsper Trading AcademyClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asterias Biotherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
